Best Rex MD Alternatives for GLP-1 Weight Loss in 2026 — 2026

Last reviewed: September 14, 2026 Last updated: September 14, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Rex MD advertises $349 per month for its Wegovy oral (pill) program and $499 per month for the branded Wegovy pen via NovoCare—both FDA-approved semaglutide pathways billed monthly. Seven checkout-verified alternatives offer compounded semaglutide and tirzepatide from $189 to $399 per month with no membership fees, same price at every dose, and transparent cost structures. Over 12 months, the price gap between Rex MD's branded offerings and the least expensive compounded alternative reaches $1,920 to $3,720 depending on medication and route. Your decision turns on whether you prioritize FDA-approved branded medication or a lower-cost compounded option, your insurance coverage for Wegovy, and whether injection or oral administration fits your preference.

At-a-glance comparison: Rex MD vs verified alternatives

Sources: Rex MD pricing from rexmd.com/weight-management/ and rexmd.com/our-medications/weight-management/semaglutide, captured September 4, 2026. Competitor pricing checkout-verified July 17–23, 2026. PlexusDx pricing from internal product catalog, confirmed September 14, 2026. All figures are month-to-month rates unless noted. 12-month totals are our calculation.

Why people look beyond Rex MD

Rex MD is a men's telehealth platform that added a weight-management pathway offering FDA-approved Wegovy through its provider network. The advertised $349 per month for the oral pill and $499 per month for the branded pen are both semaglutide options—the same active ingredient available as a compounded injection or oral capsule from specialized weight-loss telehealth providers at significantly lower cost.

Three factors drive the search for alternatives:

• Price gap over time: The difference between Rex MD's $349 oral Wegovy and a $189 compounded semaglutide injection compounds to $1,920 over 12 months. Against the $499 branded pen, the gap reaches $3,720 annually.
• Insurance non-coverage: Most commercial insurance plans exclude Wegovy for weight management unless specific comorbidities are documented. Rex MD's advertised pricing is the NovoCare self-pay cash rate, meaning users pay full retail even if they carry insurance. Compounded alternatives are self-pay by design but priced lower than the branded cash rate.
• Dose-titration cost consistency: Rex MD states "lowest cost locked across titration doses" for the oral program, but the pen program's $499 rate applies "regardless of dosage strength." Verified compounded alternatives including PlexusDx, Embody, and Peak Wellness hold the same monthly price from starting dose through maintenance, eliminating mid-titration cost surprises.

Rex MD's verified pricing comes from indexed product pages captured September 4, 2026; the figures are described as "starting" or ongoing cash prices. The platform's page timed out during checkout verification, so users should confirm all costs, membership requirements, and dose policies at enrollment.

Normalized 12-month cost comparison

Comparing ongoing month-to-month rates over 12 months isolates the medication cost from promotional periods, prepay discounts, and billing structure differences. The table below shows total annual out-of-pocket for semaglutide across Rex MD and seven checkout-verified alternatives.

12-month totals are our calculation (monthly rate × 12). Competitor figures checkout-verified July 17–23, 2026. Eden all-in rate includes required $99/month membership. PlexusDx figures reflect month-to-month pricing; 3-month and 6-month commitment rates are lower.

The least expensive verified alternative—PlexusDx compounded semaglutide injection at $189 per month—costs $2,268 over 12 months, saving $1,920 compared to Rex MD's $349 oral Wegovy and $3,720 compared to the $499 branded pen. PlexusDx tirzepatide injection, a dual GLP-1/GIP agonist often associated with greater average weight loss in clinical trials, runs $289 per month ($3,468 annually), still $720 below Rex MD's oral option and $2,520 below the pen.

Eden's $198 all-in rate ($99 medication + $99 required membership) and Peak Wellness's $249 semaglutide injection both land between PlexusDx and the mid-tier alternatives. Found, Henry Meds, Embody, and TrimRx cluster near $290–$299 per month, roughly $50–$60 below Rex MD's oral program.

FDA-approved branded vs. compounded: what changes

Rex MD's Wegovy programs deliver FDA-approved semaglutide manufactured by Novo Nordisk under New Drug Application review. The agency has evaluated the branded product for safety, effectiveness, manufacturing consistency, and labeling accuracy. Compounded semaglutide and tirzepatide—offered by PlexusDx, Eden, Peak Wellness, Found, Henry Meds, Embody, and TrimRx—are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Compounding pharmacies prepare individualized medication under section 503A of the Federal Food, Drug, and Cosmetic Act. PlexusDx works with licensed 503A compounding pharmacies. These facilities operate under state pharmacy board oversight and follow USP <797> sterile-compounding standards, but they do not submit pre-market applications to FDA. The active pharmaceutical ingredient is the same molecule (semaglutide or tirzepatide); the difference lies in regulatory pathway, manufacturing scale, and cost structure.

In practice, this means:

• Insurance coverage: Branded Wegovy may qualify for coverage if your plan includes weight-management medications and you meet medical criteria (BMI ≥27 with comorbidity or BMI ≥30). Rex MD's advertised pricing is the self-pay cash rate through NovoCare, so insurance verification happens separately. Compounded GLP-1s are not covered by insurance; the advertised price is what you pay.
• Supply continuity: Branded Wegovy has experienced intermittent shortages since 2021; Novo Nordisk prioritizes diabetes (Ozempic) production when API supply tightens. Compounded semaglutide availability depends on bulk API supply and individual pharmacy capacity; some telehealth providers report more consistent compounded inventory during branded shortages.
• Dosing flexibility: Compounding pharmacies can prepare doses in finer increments than the fixed-strength branded pens, which may help users who experience side effects during titration. Rex MD's oral Wegovy follows the manufacturer's titration schedule; the pen program uses standard Wegovy pen strengths.

Neither pathway guarantees eligibility, specific dose, or results. Both require a licensed provider to evaluate your medical history, current medications, contraindications, and weight-management goals before prescribing.

What Rex MD offers that alternatives may not

Rex MD holds two advantages for users who prioritize FDA-approved branded medication or prefer oral administration:

• Wegovy oral pill option: At $349 per month, Rex MD is the only provider in this comparison offering FDA-approved oral semaglutide for weight management. All seven checkout-verified alternatives deliver compounded semaglutide via subcutaneous injection or compounded oral capsule (PlexusDx, Henry Meds). Users with needle aversion or injection-site reactions may find the branded oral pill worth the premium, though PlexusDx compounded semaglutide oral capsules run $289 per month—$60 less than Rex MD's branded pill.
• Established branded supply chain: The Wegovy pen pathway through NovoCare connects directly to Novo Nordisk's distribution network. Users willing to pay $499 per month bypass compounding-pharmacy intermediaries and receive the same pens dispensed at retail pharmacies, with the manufacturer's packaging, labeling, and lot traceability.

These advantages narrow for users without strong preference for branded medication or oral route. A $1,920 annual premium for the oral pill or $3,720 for the pen is decision-relevant if compounded injection or oral alternatives meet your clinical needs at lower cost.

Gaps and uncertainties in Rex MD's pricing model

Three areas require confirmation at enrollment:

1. Pen-program service fees: Rex MD's indexed pages state $0 membership/service fee for the oral Wegovy program but carry the caveat "Confirm whether any separate program fee applies" to the pen pathway. The $499 figure is described as the NovoCare medication cash price; whether Rex MD adds a prescription-facilitation or platform fee is unclear from public sources captured September 4, 2026.
2. Dose-specific pricing: The oral program advertises "lowest cost locked across titration doses." The pen program states $499 "regardless of dosage strength for eligible self-pay patients." Both suggest flat pricing, but the word "starting" appears near the $349 figure on the weight-management landing page. Users should confirm whether the advertised rate applies at maintenance doses (2.4 mg weekly for semaglutide) or only at lower titration steps.
3. Eligibility restrictions: Rex MD is a men's health platform; its weight-management pathway may limit enrollment by gender, though the captured pages do not explicitly state this restriction. Users should verify eligibility criteria during intake.

The platform's checkout flow timed out during verification, so these details remain unconfirmed. The advertised figures come from Rex MD's own indexed product pages and are treated as reliable for comparison, but readers should expect to confirm all costs, billing terms, and service inclusions before submitting payment.

Where PlexusDx fits among Rex MD alternatives

PlexusDx compounded semaglutide injection costs $189 per month on a month-to-month plan—the lowest ongoing rate in this comparison—or $169 per month on a 3-month commitment and $149 per month on a 6-month commitment. No membership fee sits on top of medication cost; the published price is the recurring all-in charge for provider visit, prescription, compounded medication, and shipping. PlexusDx holds the same rate at every dose from initial titration through maintenance, so the out-of-pocket monthly cost remains $189 whether you receive 0.25 mg or 2.4 mg weekly.

PlexusDx tirzepatide injection—a dual GLP-1/GIP receptor agonist—runs $289 per month month-to-month, $269 per month on a 3-month plan, and $249 per month on a 6-month plan. Tirzepatide demonstrates greater average weight loss than semaglutide in head-to-head trials (SURMOUNT-1, SURMOUNT-2), though individual response varies and side-effect profiles differ. The $289 month-to-month rate is $60 below Rex MD's oral Wegovy and $210 below the branded pen.

PlexusDx also offers compounded semaglutide oral capsules at $289 per month and tirzepatide oral capsules at $349 per month for users who prefer not to inject. A microdose GLP-1 protocol runs $129 per month for maintenance after initial weight loss or for users seeking metabolic support at sub-clinical doses.

PlexusDx works with licensed 503A compounding pharmacies. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. Every prescription undergoes individual provider review; eligibility, medication choice, starting dose, and titration schedule depend on your medical history, current medications, and weight-management goals.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com).

Choose Rex MD Wegovy oral if…

• You strongly prefer FDA-approved branded medication and are willing to pay the $349 monthly premium for regulatory assurance.
• Oral administration is a priority and you want the branded pill rather than a compounded oral capsule.
• Your insurance covers Wegovy for weight management and you can apply the Rex MD prescription toward your pharmacy benefit, reducing out-of-pocket below the $349 self-pay rate.
• You value direct connection to Novo Nordisk's supply chain and are comfortable with the $4,188 annual cost on a month-to-month plan.

Choose Rex MD Wegovy pen if…

• You want the branded Wegovy auto-injector pen with the manufacturer's packaging and dosing device, and $499 per month ($5,988 annually) fits your budget.
• You have used branded Wegovy through insurance in the past, lost coverage, and prefer to continue the same product at the NovoCare self-pay rate rather than switch to a compounded alternative.
• You prioritize FDA-approved medication over cost savings and are comfortable with the $3,720 annual premium relative to the least expensive compounded injection alternative.

Choose a compounded alternative if…

• You want semaglutide or tirzepatide at the lowest ongoing cost, are comfortable with 503A compounded medication, and prefer transparent month-to-month pricing with no insurance billing complexity.
• You value dose flexibility during titration or need a provider who can adjust increments based on your tolerance and side-effect profile.
• You are comparing several telehealth providers and want to evaluate service quality, responsiveness, and support experience alongside price—reviews and platform ratings matter as much as medication cost over a 12-month commitment.
• You want to minimize annual out-of-pocket and are willing to evaluate compounded semaglutide injection or oral routes that cost $1,200 to $1,920 less per year than Rex MD's branded offerings.

Choose PlexusDx if…

• You want the lowest verified ongoing rate for compounded semaglutide injection ($189/month, $2,268/year) with no membership fee and the same price at every dose.
• You are interested in tirzepatide injection at $289 per month—$60 below Rex MD's oral Wegovy and $210 below the branded pen—and prefer the dual GLP-1/GIP mechanism associated with greater average weight loss in clinical trials.
• You value flexible commitment options: month-to-month at $189 semaglutide / $289 tirzepatide, or lower per-month rates on 3-month ($169/$269) or 6-month ($149/$249) plans.
• You want access to both injection and oral compounded routes (oral semaglutide $289/month, oral tirzepatide $349/month) or a microdose GLP-1 protocol ($129/month) for maintenance without switching providers.
• You prefer a provider with a verified Trustpilot profile (4.3 stars, 83% four-star-or-higher reviews) and transparent, checkout-verified pricing rather than post-questionnaire reveals.

Methodology and freshness

Rex MD pricing comes from indexed product pages at rexmd.com/weight-management/ and rexmd.com/our-medications/weight-management/semaglutide, captured September 4, 2026. The platform's checkout flow timed out during verification; figures are treated as advertised rates and readers should confirm at enrollment. Competitor pricing for Eden, Embody, Found, Henry Meds, Peak Wellness, TrimRx, and PlexusDx was checkout-verified between July 17 and July 23, 2026, with methods documented per provider (cart inspection, checkout screenshot, payment-page confirmation). PlexusDx pricing reflects the internal product catalog confirmed September 14, 2026. PlexusDx Trustpilot rating captured September 9, 2026, from trustpilot.com/review/plexusdx.com.

All 12-month totals, annual savings figures, and per-month equivalents for prepaid plans are our calculation. Compounded-medication regulatory status and disclosure language follow FDA guidance on compounding and the Federal Food, Drug, and Cosmetic Act section 503A. This comparison uses month-to-month rates as the primary benchmark; prepaid-plan per-month equivalents are noted separately and labeled as requiring upfront payment.

No provider guarantees eligibility, medication, dose, results, or side-effect outcomes. A licensed clinician reviews your medical history and determines whether a prescription is appropriate.

Frequently Asked Questions

Is Rex MD's Wegovy the same medication as compounded semaglutide?

Rex MD offers FDA-approved branded Wegovy (semaglutide) manufactured by Novo Nordisk. Compounded semaglutide uses the same active ingredient but is prepared by a 503A compounding pharmacy and is not FDA-approved. The molecule is identical; the regulatory pathway, manufacturing scale, and cost structure differ. Insurance may cover branded Wegovy if you meet medical criteria, while compounded semaglutide is self-pay only.

Why does Rex MD cost $349 to $499 per month when alternatives start at $189?

Rex MD's pricing reflects the NovoCare self-pay cash rate for branded Wegovy, which includes the manufacturer's regulatory and distribution costs. Compounded alternatives cost less because they bypass branded-drug economics and are prepared by pharmacies under 503A state oversight. The $1,920 to $3,720 annual gap between Rex MD and the least expensive compounded option is the premium for FDA-approved branded medication.

Do I save money on Rex MD if I use insurance?

Possibly. If your insurance plan covers Wegovy for weight management and you meet BMI and comorbidity criteria, your copay or coinsurance may be lower than the $349/$499 self-pay rates Rex MD advertises. However, most commercial plans exclude weight-loss medications or require prior authorization. Rex MD's advertised figures are the NovoCare cash price for users without coverage. Confirm your plan's formulary and your out-of-pocket cost before assuming insurance saves money.

Does PlexusDx charge a membership fee on top of medication cost?

No. PlexusDx's published prices—$189/month for semaglutide injection, $289/month for tirzepatide injection—are the all-in recurring charges covering provider visit, prescription, compounded medication, and shipping. No separate membership fee, service fee, or platform fee applies. The price you see is the price you pay each month on a month-to-month plan, or lower on 3-month and 6-month commitments.

Can I switch from Rex MD Wegovy to a compounded alternative mid-treatment?

Switching is possible but requires a new provider evaluation. You cannot transfer a Wegovy prescription to a compounding pharmacy; a clinician at the new telehealth provider must review your history, current dose, tolerance, and weight-loss progress, then write a new prescription for compounded semaglutide if appropriate. Dose timing and titration continuity depend on the receiving provider's protocol. Neither Rex MD nor any alternative guarantees seamless transfers.

Sources

• Rex MD Weight Management Program: https://rexmd.com/weight-management/ (accessed September 4, 2026)
• Rex MD Semaglutide (Wegovy) Product Page: https://rexmd.com/our-medications/weight-management/semaglutide (accessed September 4, 2026)
• Competitor Pricing Verification Report (Eden, Embody, Found, Henry Meds, Peak Wellness, TrimRx): checkout-verified July 17–23, 2026; internal research file
• PlexusDx Product Catalog: internal pricing table, confirmed September 14, 2026
• PlexusDx Trustpilot Profile: https://www.trustpilot.com/review/plexusdx.com (accessed September 9, 2026)
• FDA Guidance on Compounding: Federal Food, Drug, and Cosmetic Act section 503A; FDA compounding and repackaging information
• USP General Chapter <797>: Pharmaceutical Compounding—Sterile Preparations

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.